This is because our understanding of the risk conferred by FH variants comes from studying families who have been tested and diagnosed because multiple members have had kidney cancers—and even in these families, the majority of people with a cancer-predisposing FH variant will not develop kidney cancer. The gene discussed is FH; the disease is kidney cancer.